Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Overview of attention for article published in New England Journal of Medicine, September 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 6 news outlets
blogs: 6 blogs
policy: 3 policy sources
twitter: 4 X users

patent: 6 patents
wikipedia: 1 Wikipedia page
f1000: 1 research highlight platform
guideline: 12 clinical guideline sources

Readers on

mendeley: 975 Mendeley
citeulike: 2 CiteULike
connotea: 2 Connotea

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,030 followers.

In patients with HFrEF (EF130ms, with mild or no symptoms corresponding to NYHA class I-ll) CRT-D is more advantageous compared to ICD implantation alone. Source:MADIT-CRT Trial, NEJM 2009 🔗 https://t.co/roacmO3XdY Note: Educational purposes only. This…

@strain_rate @argulian I agree. But they use in research that shows improvement in ejection fraction with resynchronisation! https://t.co/u9Nd5VMNZ2 https://t.co/Tv2VgrFPWQ

@jfdwolff @ProfDFrancis @psmedic @jfdwolff https://t.co/3DbijPZXoU MADIT-CRT - patients with minimal or no symptoms.

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events — NEJM http://t.co/dj2WOc6HN8

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.